HealthVerity Clinical Trial Optimization Approach Considers RWD Advantages and Promotes Equity

RWD (real world data) is changing the way clinical trials are designed and conducted. HealthVerity discusses important consideration for using RWD in clinical trials, including better integration methods so that researchers can more easily draw conclusions from their data. In addition, the use of RWD can contribute to fulfilling regulatory requirements. HealthVerity also remarks that its Provider Diversity Index ensures that minority groups are included in clinical trials.

“Up until now clinical trial data and real-world data have existed as separate silos, blocking insights into what’s happening to patients both before and after the trial. By expanding your vision of each patient beyond the constraints and time period of the clinical trial, you can now take advantage of key missed opportunities in clinical trial development and execution.” Learn more here.

(Source: HealthVerity, 2021)